Simple Nerve Stimulation May Improve Sexual Response in Women

A treatment designed to improve bladder dysfunction could have another use: helping women who struggle to achieve sexual arousal.

7:00 AM

Author | Kelly Malcom

Electrodes aren't the first thing most people think of when it comes to achieving sexual arousal. But if the results of a pilot study are any indication, that may soon change.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Female sexual dysfunction, a condition that ranges from a lack of libido to an inability to achieve orgasm, affects 40 to 45 percent of women, especially as they age.

Female sexual dysfunction can be tough to diagnose and even more difficult to treat.

And while clinicians have attempted to help women by prescribing sildenafil (better known by the brand name Viagra), hormones and flibanserin a drug intended to improve sexual response that was recently approved by the Food and Drug Administration these methods don't always work. They also can have undesirable side effects.

That's why two University of Michigan researchers were intrigued after learning that neuromodulation treatments for bladder dysfunction occasionally led to improvements in sexual function.

"In this particular treatment, a patient receives nerve stimulation therapy once a week to improve neural signaling and function in the muscles that control the bladder," says Tim Bruns, Ph.D., an assistant professor of biomedical engineering at U-M. "The nerves controlling the pelvic organs start out in the same location in the spinal cord and branch out."

Interestingly, Bruns notes, one form of stimulation is effective for bladder dysfunction despite an odd placement of the electrodes: near the tibial nerve in the ankle.

The current theory, Bruns explains, is that the nerves that travel down to the foot overlap near the spinal cord with some of the nerves to the pelvic organs, leading to a possible overlap in synaptic routes.

Sensing an opportunity, Bruns and his colleague, Nicholas Langhals, Ph.D., looked into whether the technique had been investigated in women without bladder problems.

Surprisingly, there was almost no research.

Testing a theory

Bruns studied the technique in rats and humans.

In the rat studies published last year and this year, Bruns' team stimulated nerves in the genital and ankle region. After 15 to 30 minutes, the rodents experienced a strong increase in vaginal blood flow.

MORE FROM THE LAB: Subscribe to our weekly newsletter

Then, working with Michigan Medicine OB-GYN Mitchell Berger, M.D., Ph.D., and urologic surgeon Priyanka Gupta, M.D., the researchers recruited nine women with female sexual dysfunction (and without bladder problems) for a pilot study.

Each woman received 12 half-hour sessions of transcutaneous electrical nerve stimulation in which participants had electrodes placed either in the genital region or on the ankle.

A 53-year-old woman who got involved with the study after reporting to her gynecologist that she had difficulty achieving orgasm described the experience as "a bizarre pressure vibration sensation."

Still, she managed.

"After a few minutes, you get used to it," the participant recalled. "Then you sit there for 30 minutes. I brought a book to read during my session."

Electrodes boost sexual function

Results of the sessions showed substantial promise: Eight of the 9 women reported some improvement in arousal, lubrication and orgasm.

"Across a variety of clinical studies, if you get a 50 percent improvement in symptoms, you can consider that a successful response," Bruns says. "We had four participants meet or exceed that threshold."

SEE ALSO: Sex After 65: Poll Finds Gender Differences, Lack of Communication

Overall improvement in score was comparable to or greater than prior studies of different drugs or neuromodulation for female sexual dysfunction, he adds. However, future studies with blinding and a placebo control are needed to rule out any placebo effect.

This study, published in Neuromodulation, was funded in part by a grant from the Michigan Institute for Clinical and Health Research, which is funded by the National Institutes of Health.

More research planned

Bolstered by these early findings, the Michigan team is seeking funding for a larger study.

Says Gupta: "This study presents an alternative method for treating female sexual dysfunction that is nonpharmacologic and noninvasive. Through studies like this, we can further understand female sexual arousal and offer treatments for a disorder that has very few options."

The treatment has at least one fan: the participant interviewed about her experience.

"It worked for me," she says. "I'm not 100 percent back to the way I was, but I can have orgasms again and they are pretty good ones."


More Articles About:

Body Work Sexual Health Womens Health Gynecology Basic Science and Laboratory Research All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

woman looking at screen in office clinical area
Health Lab

How AI is helping emergency physicians learn from their patients

How the “Tell Me What Happens Next” initiative is being used by the Department of Emergency Medicine’s new Division of Clinical Informatics using artificial intelligence.
baby with hearing aid on ear looking from side view with blue pacifier in mouth
Health Lab

Research may help better predict outcomes in kids with congenital cytomegalovirus

Two new studies may help researchers and clinicians better understand congenital cytomegalovirus (CMV), the most common infectious cause of birth defects and a leading cause of non-genetic hearing loss in children.
couple walking by the water
Health Lab

Michigan’s aging brains need more protection, poll shows

Lifestyle changes can reduce risk of Alzheimer’s disease and other forms of dementia but a poll shows many Michiganders over 50 don’t know about or do them.
purple yellow red cells up close
Health Lab

Study explains how colorectal cancer cells maintain high iron levels

How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
On left side, a ReacStick is being dropped. A hand is reaching out to grab the stick with green lights illuminated. On the right side, the ReacStick is being dropped with no lights illuminated. The hand is letting the stick fall.
Health Lab

A method to prevent falls before they happen

To prevent falls, the JEDII Fall Clinic at University of Michigan Health has specialized tests they use to measure whether you could be at a fall risk before it happens
eyes looking pink background looking at cell tracker
Health Lab

When should parents stop tracking their kids' location?

Some parents may be crossing a line with tracking their young adult kids’ locations, according to a new national poll.